7-17% diabetes prevalence in initial screening in India
New Delhi: Between 7 to 16 per cent people suffer from diabetes in India, as per preliminary results of screening of five lakh people in 100 districts under the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS).
Pointing out this here today, Health Secretary P K Pradhan said the government is now initiating steps to speed up the programme and ensure that 5 crore people in the 100 districts were screened by March next year.
Admitting that the programme (NPCDCS) was running behind schedule, Pradhan said a rapid round of the programme would soon be initiated for completing the screening of people in all the selected districts.
He said the programme has started only in 30 districts out of the earmarked 100 districts but are yet to begin in Uttar Pradesh and Jharkhand.
He said UP and Jharkhand have signed an MoU and would get an approval from their state finance departments within a week for starting the programme.
The programme was funded 80 per cent through central funds and the states were to contribute only 20 per cent for it. The Centre has already released a sum of Rs 35.71 crore for the year 2010-11, of which Rs 28.67 crore was for Diabetes, CVDs and Stroke in 27 districts and another Rs 7.04 crore for cancer.
For 2011-12, the Centre has released Rs 63.31 crore for diabetes, CVDs and stroke for 53 districts and another Rs 38.44 crore for cancer screening in 47 districts.
Under the programme, the government plans to screen a total of 5 crore people across 100 selected districts in the country.
The programme would be conducted at 20,000 sub-centres all over the country, with each sub-centre screening 25,000 people.
The government has so far released a total of Rs 137.46 for the last two years under this programme.
After the programme ends, the government intends to launch a programme in other parts of the country to screen the rest of the population for ascertaining various diseases like cancer, diabetes, stroke and various cardio-vascular diseases.